Global Radiopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Publisher Name :
Date: 14-Aug-2020
No. of pages: 131
Inquire Before Buying

Radiopharmaceuticals market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

Segment by Type, the Radiopharmaceuticals market is segmented into

- Diagnostic Radioisotopes

- Therapeutic Radioisotopes

Segment by Application, the Radiopharmaceuticals market is segmented into

- Oncology

- Cardiology

- Other

Regional and Country-level Analysis:

- North America

- - United States

- - Canada

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Competitive Landscape and Radiopharmaceuticals Market Share Analysis

Radiopharmaceuticals market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Radiopharmaceuticals product introduction, recent developments, Radiopharmaceuticals sales by region, type, application and by sales channel.

The major companies include:

- Bracco Imaging

- Bayer

- Mallinckrodt

- Nordion

- Triad Isotopes

- Lantheus

- IBA Group

- GE Healthcare

- China Isotope & Radiation

- Jubilant Pharma

- Eli Lilly

- Advanced Accelerator Applications

- SIEMENS

- Dongcheng

- Navidea

Global Radiopharmaceuticals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Table of Contents
1 Study Coverage
1.1 Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceuticals Market Size Growth Rate by Type
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Market by Application
1.3.1 Global Radiopharmaceuticals Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals Market Size Estimates and Forecasts
2.1.1 Global Radiopharmaceuticals Revenue 2015-2026
2.1.2 Global Radiopharmaceuticals Sales 2015-2026
2.2 Radiopharmaceuticals Market Size by Region: 2020 Versus 2026
2.3 Radiopharmaceuticals Sales by Region (2015-2026)
2.3.1 Global Radiopharmaceuticals Sales by Region: 2015-2020
2.3.2 Global Radiopharmaceuticals Sales Forecast by Region (2021-2026)
2.3.3 Global Radiopharmaceuticals Sales Market Share by Region (2015-2026)
2.4 Radiopharmaceuticals Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Radiopharmaceuticals Revenue by Region: 2015-2020
2.4.2 Global Radiopharmaceuticals Revenue Forecast by Region (2021-2026)
2.4.3 Global Radiopharmaceuticals Revenue Market Share by Region (2015-2026)
3 Global Radiopharmaceuticals by Manufacturers
3.1 Global Top Radiopharmaceuticals Manufacturers by Sales
3.1.1 Global Radiopharmaceuticals Sales by Manufacturer (2015-2020)
3.1.2 Global Radiopharmaceuticals Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Radiopharmaceuticals Manufacturers by Revenue
3.2.1 Global Radiopharmaceuticals Revenue by Manufacturer (2015-2020)
3.2.2 Global Radiopharmaceuticals Revenue Share by Manufacturer (2015-2020)
3.3 Global Radiopharmaceuticals Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
3.4.2 Global Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Radiopharmaceuticals Manufacturing Base Distribution, Product Type
3.5.1 Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Radiopharmaceuticals Product Type
3.5.3 Date of International Manufacturers Enter into Radiopharmaceuticals Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Bracco Imaging
4.1.1 Bracco Imaging Corporation Information
4.1.2 Bracco Imaging Description, Business Overview
4.1.3 Bracco Imaging Radiopharmaceuticals Products Offered
4.1.4 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Bracco Imaging Radiopharmaceuticals Revenue by Product
4.1.6 Bracco Imaging Radiopharmaceuticals Revenue by Application
4.1.7 Bracco Imaging Radiopharmaceuticals Revenue by Geographic Area
4.1.8 Bracco Imaging Radiopharmaceuticals Revenue by Sales Channel
4.1.9 Bracco Imaging Recent Development
4.2 Bayer
4.2.1 Bayer Corporation Information
4.2.2 Bayer Description, Business Overview
4.2.3 Bayer Radiopharmaceuticals Products Offered
4.2.4 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Bayer Radiopharmaceuticals Revenue by Product
4.2.6 Bayer Radiopharmaceuticals Revenue by Application
4.2.7 Bayer Radiopharmaceuticals Revenue by Geographic Area
4.2.8 Bayer Radiopharmaceuticals Revenue by Sales Channel
4.2.9 Bayer Recent Development
4.3 Mallinckrodt
4.3.1 Mallinckrodt Corporation Information
4.3.2 Mallinckrodt Description, Business Overview
4.3.3 Mallinckrodt Radiopharmaceuticals Products Offered
4.3.4 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.3.5 Mallinckrodt Radiopharmaceuticals Revenue by Product
4.3.6 Mallinckrodt Radiopharmaceuticals Revenue by Application
4.3.7 Mallinckrodt Radiopharmaceuticals Revenue by Geographic Area
4.3.8 Mallinckrodt Radiopharmaceuticals Revenue by Sales Channel
4.3.9 Mallinckrodt Recent Development
4.4 Nordion
4.4.1 Nordion Corporation Information
4.4.2 Nordion Description, Business Overview
4.4.3 Nordion Radiopharmaceuticals Products Offered
4.4.4 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Nordion Radiopharmaceuticals Revenue by Product
4.4.6 Nordion Radiopharmaceuticals Revenue by Application
4.4.7 Nordion Radiopharmaceuticals Revenue by Geographic Area
4.4.8 Nordion Radiopharmaceuticals Revenue by Sales Channel
4.4.9 Nordion Recent Development
4.5 Triad Isotopes
4.5.1 Triad Isotopes Corporation Information
4.5.2 Triad Isotopes Description, Business Overview
4.5.3 Triad Isotopes Radiopharmaceuticals Products Offered
4.5.4 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Triad Isotopes Radiopharmaceuticals Revenue by Product
4.5.6 Triad Isotopes Radiopharmaceuticals Revenue by Application
4.5.7 Triad Isotopes Radiopharmaceuticals Revenue by Geographic Area
4.5.8 Triad Isotopes Radiopharmaceuticals Revenue by Sales Channel
4.5.9 Triad Isotopes Recent Development
4.6 Lantheus
4.6.1 Lantheus Corporation Information
4.6.2 Lantheus Description, Business Overview
4.6.3 Lantheus Radiopharmaceuticals Products Offered
4.6.4 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.6.5 Lantheus Radiopharmaceuticals Revenue by Product
4.6.6 Lantheus Radiopharmaceuticals Revenue by Application
4.6.7 Lantheus Radiopharmaceuticals Revenue by Geographic Area
4.6.8 Lantheus Recent Development
4.7 IBA Group
4.7.1 IBA Group Corporation Information
4.7.2 IBA Group Description, Business Overview
4.7.3 IBA Group Radiopharmaceuticals Products Offered
4.7.4 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.7.5 IBA Group Radiopharmaceuticals Revenue by Product
4.7.6 IBA Group Radiopharmaceuticals Revenue by Application
4.7.7 IBA Group Radiopharmaceuticals Revenue by Geographic Area
4.7.8 IBA Group Recent Development
4.8 GE Healthcare
4.8.1 GE Healthcare Corporation Information
4.8.2 GE Healthcare Description, Business Overview
4.8.3 GE Healthcare Radiopharmaceuticals Products Offered
4.8.4 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.8.5 GE Healthcare Radiopharmaceuticals Revenue by Product
4.8.6 GE Healthcare Radiopharmaceuticals Revenue by Application
4.8.7 GE Healthcare Radiopharmaceuticals Revenue by Geographic Area
4.8.8 GE Healthcare Recent Development
4.9 China Isotope & Radiation
4.9.1 China Isotope & Radiation Corporation Information
4.9.2 China Isotope & Radiation Description, Business Overview
4.9.3 China Isotope & Radiation Radiopharmaceuticals Products Offered
4.9.4 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.9.5 China Isotope & Radiation Radiopharmaceuticals Revenue by Product
4.9.6 China Isotope & Radiation Radiopharmaceuticals Revenue by Application
4.9.7 China Isotope & Radiation Radiopharmaceuticals Revenue by Geographic Area
4.9.8 China Isotope & Radiation Recent Development
4.10 Jubilant Pharma
4.10.1 Jubilant Pharma Corporation Information
4.10.2 Jubilant Pharma Description, Business Overview
4.10.3 Jubilant Pharma Radiopharmaceuticals Products Offered
4.10.4 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.10.5 Jubilant Pharma Radiopharmaceuticals Revenue by Product
4.10.6 Jubilant Pharma Radiopharmaceuticals Revenue by Application
4.10.7 Jubilant Pharma Radiopharmaceuticals Revenue by Geographic Area
4.10.8 Jubilant Pharma Recent Development
4.11 Eli Lilly
4.11.1 Eli Lilly Corporation Information
4.11.2 Eli Lilly Description, Business Overview
4.11.3 Eli Lilly Radiopharmaceuticals Products Offered
4.11.4 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.11.5 Eli Lilly Radiopharmaceuticals Revenue by Product
4.11.6 Eli Lilly Radiopharmaceuticals Revenue by Application
4.11.7 Eli Lilly Radiopharmaceuticals Revenue by Geographic Area
4.11.8 Eli Lilly Recent Development
4.12 Advanced Accelerator Applications
4.12.1 Advanced Accelerator Applications Corporation Information
4.12.2 Advanced Accelerator Applications Description, Business Overview
4.12.3 Advanced Accelerator Applications Radiopharmaceuticals Products Offered
4.12.4 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.12.5 Advanced Accelerator Applications Radiopharmaceuticals Revenue by Product
4.12.6 Advanced Accelerator Applications Radiopharmaceuticals Revenue by Application
4.12.7 Advanced Accelerator Applications Radiopharmaceuticals Revenue by Geographic Area
4.12.8 Advanced Accelerator Applications Recent Development
4.13 SIEMENS
4.13.1 SIEMENS Corporation Information
4.13.2 SIEMENS Description, Business Overview
4.13.3 SIEMENS Radiopharmaceuticals Products Offered
4.13.4 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.13.5 SIEMENS Radiopharmaceuticals Revenue by Product
4.13.6 SIEMENS Radiopharmaceuticals Revenue by Application
4.13.7 SIEMENS Radiopharmaceuticals Revenue by Geographic Area
4.13.8 SIEMENS Recent Development
4.14 Dongcheng
4.14.1 Dongcheng Corporation Information
4.14.2 Dongcheng Description, Business Overview
4.14.3 Dongcheng Radiopharmaceuticals Products Offered
4.14.4 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.14.5 Dongcheng Radiopharmaceuticals Revenue by Product
4.14.6 Dongcheng Radiopharmaceuticals Revenue by Application
4.14.7 Dongcheng Radiopharmaceuticals Revenue by Geographic Area
4.14.8 Dongcheng Recent Development
4.15 Navidea
4.15.1 Navidea Corporation Information
4.15.2 Navidea Description, Business Overview
4.15.3 Navidea Radiopharmaceuticals Products Offered
4.15.4 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
4.15.5 Navidea Radiopharmaceuticals Revenue by Product
4.15.6 Navidea Radiopharmaceuticals Revenue by Application
4.15.7 Navidea Radiopharmaceuticals Revenue by Geographic Area
4.15.8 Navidea Recent Development
5 Breakdown Data by Type
5.1 Global Radiopharmaceuticals Sales by Type (2015-2026)
5.1.1 Global Radiopharmaceuticals Sales by Type (2015-2020)
5.1.2 Global Radiopharmaceuticals Sales Forecast by Type (2021-2026)
5.1.3 Global Radiopharmaceuticals Sales Market Share by Type (2015-2026)
5.2 Global Radiopharmaceuticals Revenue Forecast by Type (2015-2026)
5.2.1 Global Radiopharmaceuticals Revenue by Type (2015-2020)
5.2.2 Global Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
5.2.3 Global Radiopharmaceuticals Revenue Market Share by Type (2015-2026)
5.3 Radiopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Radiopharmaceuticals Sales by Application (2015-2026)
6.1.1 Global Radiopharmaceuticals Sales by Application (2015-2020)
6.1.2 Global Radiopharmaceuticals Sales Forecast by Application (2021-2026)
6.1.3 Global Radiopharmaceuticals Sales Market Share by Application (2015-2026)
6.2 Global Radiopharmaceuticals Revenue Forecast by Application (2015-2026)
6.2.1 Global Radiopharmaceuticals Revenue by Application (2015-2020)
6.2.2 Global Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
6.2.3 Global Radiopharmaceuticals Revenue Market Share by Application (2015-2026)
6.3 Radiopharmaceuticals Average Selling Price (ASP) by Application (2015-2026)
7 North America
7.1 North America Radiopharmaceuticals Market Size YoY Growth 2015-2026
7.2 North America Radiopharmaceuticals Market Facts & Figures by Country
7.2.1 North America Radiopharmaceuticals Sales by Country (2015-2026)
7.2.2 North America Radiopharmaceuticals Revenue by Country (2015-2026)
7.3 North America Radiopharmaceuticals Sales by Type
7.4 North America Radiopharmaceuticals Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceuticals Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Radiopharmaceuticals Market Facts & Figures by Region
8.2.1 Asia-Pacific Radiopharmaceuticals Sales by Region (2015-2026)
8.2.2 Asia-Pacific Radiopharmaceuticals Revenue by Region (2015-2026)
8.3 Asia-Pacific Radiopharmaceuticals Sales by Type
8.4 Asia-Pacific Radiopharmaceuticals Sales by Application
9 Europe
9.1 Europe Radiopharmaceuticals Market Size YoY Growth 2015-2026
9.2 Europe Radiopharmaceuticals Market Facts & Figures by Country
9.2.1 Europe Radiopharmaceuticals Sales by Country (2015-2026)
9.2.2 Europe Radiopharmaceuticals Revenue by Country (2015-2026)
9.3 Europe Radiopharmaceuticals Sales by Type
9.4 Europe Radiopharmaceuticals Sales by Application
10 Latin America
10.1 Latin America Radiopharmaceuticals Market Size YoY Growth 2015-2026
10.2 Latin America Radiopharmaceuticals Market Facts & Figures by Country
10.2.1 Latin America Radiopharmaceuticals Sales by Country (2015-2026)
10.2.2 Latin America Radiopharmaceuticals Revenue by Country (2015-2026)
10.3 Latin America Radiopharmaceuticals Sales by Type
10.4 Latin America Radiopharmaceuticals Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Radiopharmaceuticals Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Radiopharmaceuticals Market Facts & Figures by Country
11.2.1 Middle East and Africa Radiopharmaceuticals Sales by Country (2015-2026)
11.2.2 Middle East and Africa Radiopharmaceuticals Revenue by Country (2015-2026)
11.3 Middle East and Africa Radiopharmaceuticals Sales by Type
11.4 Middle East and Africa Radiopharmaceuticals Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Radiopharmaceuticals Supply Chain Analysis
12.2 Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
12.3 Radiopharmaceuticals Clients Analysis
12.4 Radiopharmaceuticals Sales Channel and Sales Model Analysis
12.4.1 Radiopharmaceuticals Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Radiopharmaceuticals Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Radiopharmaceuticals Distributors
13 Market Dynamics
13.1 Radiopharmaceuticals Market Drivers
13.2 Radiopharmaceuticals Market Opportunities
13.3 Radiopharmaceuticals Market Challenges
13.4 Radiopharmaceuticals Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Major Manufacturers of Diagnostic Radioisotopes
Table 3. Major Manufacturers of Therapeutic Radioisotopes
Table 4. Global Radiopharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 5. Global Radiopharmaceuticals Market Size by Region (US$ Million): 2020 VS 2026
Table 6. Global Radiopharmaceuticals Sales by Region (2015-2020) & (K Dose)
Table 7. Global Radiopharmaceuticals Sales Forecast by Region (2021-2026) & (K Dose)
Table 8. Global Radiopharmaceuticals Revenue by Region (2015-2020) & (US$ Million)
Table 9. Global Radiopharmaceuticals Revenue Forecast by Region (2021-2026) & (US$ Million)
Table 10. Global Radiopharmaceuticals Sales by Manufacturer (2015-2020) & (K Dose)
Table 11. Global Radiopharmaceuticals Sales Share by Manufacturer (2015-2020)
Table 12. Radiopharmaceuticals Revenue by Manufacturer (2015-2020) & (US$ Million)
Table 13. Radiopharmaceuticals Revenue Share by Manufacturer (2015-2020)
Table 14. Key Manufacturers Radiopharmaceuticals Price (2015-2020) & (USD/Dose)
Table 15. Ranking of Global Top Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 16. Global Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)
Table 17. Global Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2019)
Table 18. Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Radiopharmaceuticals Product Type
Table 20. Date of International Manufacturers Enter into Radiopharmaceuticals Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Bracco Imaging Corporation Information
Table 23. Bracco Imaging Description and Business Overview
Table 24. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 25. Bracco Imaging Radiopharmaceuticals Product
Table 26. Bracco Imaging Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 27. Bracco Imaging Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 28. Bracco Imaging Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 29. Bracco Imaging Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 30. Bracco Imaging Recent Development
Table 31. Bayer Corporation Information
Table 32. Bayer Description and Business Overview
Table 33. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 34. Bayer Radiopharmaceuticals Product
Table 35. Bayer Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 36. Bayer Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 37. Bayer Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 38. Bayer Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 39. Bayer Recent Development
Table 40. Mallinckrodt Corporation Information
Table 41. Mallinckrodt Description and Business Overview
Table 42. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 43. Mallinckrodt Radiopharmaceuticals Product
Table 44. Mallinckrodt Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 45. Mallinckrodt Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 46. Mallinckrodt Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 47. Mallinckrodt Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 48. Mallinckrodt Recent Development
Table 49. Nordion Corporation Information
Table 50. Nordion Description and Business Overview
Table 51. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 52. Nordion Radiopharmaceuticals Product
Table 53. Nordion Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 54. Nordion Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 55. Nordion Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 56. Nordion Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 57. Nordion Recent Development
Table 58. Triad Isotopes Corporation Information
Table 59. Triad Isotopes Description and Business Overview
Table 60. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 61. Triad Isotopes Radiopharmaceuticals Product
Table 62. Triad Isotopes Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 63. Triad Isotopes Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 64. Triad Isotopes Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 65. Triad Isotopes Radiopharmaceuticals Revenue (US$ Million) and Market Share by Sales Channel
Table 66. Triad Isotopes Recent Development
Table 67. Lantheus Corporation Information
Table 68. Lantheus Description and Business Overview
Table 69. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 70. Lantheus Radiopharmaceuticals Product
Table 71. Lantheus Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 72. Lantheus Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 73. Lantheus Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 74. Lantheus Recent Development
Table 75. IBA Group Corporation Information
Table 76. IBA Group Description and Business Overview
Table 77. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. IBA Group Radiopharmaceuticals Product
Table 79. IBA Group Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 80. IBA Group Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 81. IBA Group Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 82. IBA Group Recent Development
Table 83. GE Healthcare Corporation Information
Table 84. GE Healthcare Description and Business Overview
Table 85. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 86. GE Healthcare Radiopharmaceuticals Product
Table 87. GE Healthcare Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 88. GE Healthcare Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 89. GE Healthcare Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 90. GE Healthcare Recent Development
Table 91. China Isotope & Radiation Corporation Information
Table 92. China Isotope & Radiation Description and Business Overview
Table 93. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 94. China Isotope & Radiation Radiopharmaceuticals Product
Table 95. China Isotope & Radiation Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 96. China Isotope & Radiation Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 97. China Isotope & Radiation Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 98. China Isotope & Radiation Recent Development
Table 99. Jubilant Pharma Corporation Information
Table 100. Jubilant Pharma Description and Business Overview
Table 101. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Jubilant Pharma Radiopharmaceuticals Product
Table 103. Jubilant Pharma Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 104. Jubilant Pharma Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 105. Jubilant Pharma Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 106. Jubilant Pharma Recent Development
Table 107. Eli Lilly Corporation Information
Table 108. Eli Lilly Description and Business Overview
Table 109. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 110. Eli Lilly Radiopharmaceuticals Product
Table 111. Eli Lilly Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 112. Eli Lilly Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 113. Eli Lilly Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 114. Eli Lilly Recent Development
Table 115. Advanced Accelerator Applications Corporation Information
Table 116. Advanced Accelerator Applications Description and Business Overview
Table 117. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 118. Advanced Accelerator Applications Radiopharmaceuticals Product
Table 119. Advanced Accelerator Applications Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 120. Advanced Accelerator Applications Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 121. Advanced Accelerator Applications Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 122. Advanced Accelerator Applications Recent Development
Table 123. SIEMENS Corporation Information
Table 124. SIEMENS Description and Business Overview
Table 125. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 126. SIEMENS Radiopharmaceuticals Product
Table 127. SIEMENS Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 128. SIEMENS Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 129. SIEMENS Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 130. SIEMENS Recent Development
Table 131. Dongcheng Corporation Information
Table 132. Dongcheng Description and Business Overview
Table 133. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 134. Dongcheng Radiopharmaceuticals Product
Table 135. Dongcheng Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 136. Dongcheng Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 137. Dongcheng Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 138. Dongcheng Recent Development
Table 139. Navidea Corporation Information
Table 140. Navidea Description and Business Overview
Table 141. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 142. Navidea Radiopharmaceuticals Product
Table 143. Navidea Radiopharmaceuticals Revenue (US$ Million) and Market Share by Product
Table 144. Navidea Radiopharmaceuticals Revenue (US$ Million) and Market Share by Application
Table 145. Navidea Radiopharmaceuticals Revenue (US$ Million) and Market Share by Geographic Area
Table 146. Navidea Recent Development
Table 147. Global Radiopharmaceuticals Sales by Type (2015-2020) & (K Dose)
Table 148. Global Radiopharmaceuticals Sales Forecast by Type (2021-2026) & (K Dose)
Table 149. Global Radiopharmaceuticals Revenue by Type (2015-2020) & (US$ Million)
Table 150. Global Radiopharmaceuticals Revenue Forecast by Type (2021-2026) & (US$ Million)
Table 151. Global Radiopharmaceuticals Sales by Application (2015-2020) & (K Dose)
Table 152. Global Radiopharmaceuticals Sales Forecast by Application (2021-2026) & (K Dose)
Table 153. Global Radiopharmaceuticals Revenue by Application (2015-2020) & (US$ Million)
Table 154. Global Radiopharmaceuticals Revenue Forecast by Application (2021-2026) & (US$ Million)
Table 155. North America Radiopharmaceuticals Sales by Country (2015-2020) & (K Dose)
Table 156. North America Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose)
Table 157. North America Radiopharmaceuticals Revenue by Country (2015-2020) & (US$ Million)
Table 158. North America Radiopharmaceuticals Revenue by Country (2021-2026) & (US$ Million)
Table 159. North America Radiopharmaceuticals Sales by Type (2015-2020) & (K Dose)
Table 160. North America Radiopharmaceuticals Sales by Application (2015-2020) & (K Dose)
Table 161. Asia-Pacific Radiopharmaceuticals Sales by Region (2015-2020) & (K Dose)
Table 162. Asia-Pacific Radiopharmaceuticals Sales by Region (2021-2026) & (K Dose)
Table 163. Asia-Pacific Radiopharmaceuticals Revenue by Region (2015-2026) & (US$ Million)
Table 164. Asia-Pacific Radiopharmaceuticals Revenue by Region (2021-2026) & (US$ Million)
Table 165. Asia-Pacific Radiopharmaceuticals Sales by Type (2015-2020) & (K Dose)
Table 166. Asia-Pacific Radiopharmaceuticals Sales by Application (2015-2020) & (K Dose)
Table 167. Europe Radiopharmaceuticals Sales by Country (2015-2020) & (K Dose)
Table 168. Europe Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose)
Table 169. Europe Radiopharmaceuticals Revenue by Country (2015-2020) & (US$ Million)
Table 170. Europe Radiopharmaceuticals Revenue by Country (2021-2026) & (US$ Million)
Table 171. Europe Radiopharmaceuticals Sales by Type (2015-2020) & (K Dose)
Table 172. Europe Radiopharmaceuticals Sales by Application (2015-2020) & (K Dose)
Table 173. Latin America Radiopharmaceuticals Sales by Country (2015-2020) & (K Dose)
Table 174. Latin America Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose)
Table 175. Latin America Radiopharmaceuticals Revenue by Country (2015-2020) & (US$ Million)
Table 176. Latin America Radiopharmaceuticals Revenue by Country (2021-2026) & (US$ Million)
Table 177. Latin America Radiopharmaceuticals Sales by Type (2015-2020) & (K Dose)
Table 178. Latin America Radiopharmaceuticals Sales by Application (2015-2020) & (K Dose)
Table 179. Middle East and Africa Radiopharmaceuticals Sales by Country (2015-2020) & (K Dose)
Table 180. Middle East and Africa Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose)
Table 181. Middle East and Africa Radiopharmaceuticals Revenue by Country (2015-2020) & (US$ Million)
Table 182. Middle East and Africa Radiopharmaceuticals Revenue by Country (2021-2026) & (US$ Million)
Table 183. Middle East and Africa Radiopharmaceuticals Sales by Type (2015-2020) & (K Dose)
Table 184. Middle East and Africa Radiopharmaceuticals Sales by Application (2015-2020) & (K Dose)
Table 185. Radiopharmaceuticals Key Raw Materials, Industry Status and Trend
Table 186. Radiopharmaceuticals Key Raw Materials and Upstream Suppliers
Table 187. Radiopharmaceuticals Clients Status and Trend
Table 188. Radiopharmaceuticals Typical Clients
Table 189. Radiopharmaceuticals Distributors
Table 190. Key Drivers: Impact Analysis (2021-2026)
Table 191. Radiopharmaceuticals Market Drivers
Table 192. Radiopharmaceuticals Market Opportunities
Table 193. Radiopharmaceuticals Market Challenges
Table 194. Radiopharmaceuticals Market Restraints
Table 195. Radiopharmaceuticals Porter's Five Forces Analysis
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceuticals Product Picture
Figure 2. Global Radiopharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Diagnostic Radioisotopes Product Picture
Figure 4. Therapeutic Radioisotopes Product Picture
Figure 5. Global Radiopharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 6. Oncology Examples
Figure 7. Cardiology Examples
Figure 8. Other Examples
Figure 9. Radiopharmaceuticals Report Years Considered
Figure 10. Global Radiopharmaceuticals Market Size, (US$ Million), 2015 VS 2020 VS 2026
Figure 11. Global Radiopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 12. Global Radiopharmaceuticals Sales 2015-2026 (K Units)
Figure 13. Global Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Radiopharmaceuticals Sales Market Share Forecast by Region (2015-2026)
Figure 15. Global Radiopharmaceuticals Revenue Market Share by Region (2015-2026)
Figure 16. Global Radiopharmaceuticals Sales Share by Manufacturer in 2019
Figure 17. Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Radiopharmaceuticals Sales Market Share Forecast by Type (2015-2026)
Figure 19. Glob
  • Global Radiopharmaceuticals Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 08-Oct-2020        Price: US 3400 Onwards        Pages: 109
    The Radiopharmaceuticals market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Radiopharmaceuticals market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Radiopharmaceuticals market. The report focuses on well-known providers in the global Radiopharmaceuticals industry, market segments, competition,......
  • Global Radiopharmaceutical Market Growth 2020-2025
    Published: 06-Oct-2020        Price: US 3660 Onwards        Pages: 159
    According to this study, over the next five years the Radiopharmaceutical market will register a 8.9%% CAGR in terms of revenue, the global market size will reach $ 8076 million by 2025, from $ 5737.8 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Radiopharmaceutical business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical market......
  • Global Radiopharmaceuticals Market Growth 2020-2025
    Published: 21-Sep-2020        Price: US 3660 Onwards        Pages: 158
    According to this study, over the next five years the Radiopharmaceuticals market will register a 8.3%% CAGR in terms of revenue, the global market size will reach $ 7754.3 million by 2025, from $ 5637 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Radiopharmaceuticals business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals mar......
  • 2020-2029 Report on Global Radiopharmaceutical Market by Player, Region, Type, Application and Sales Channel
    Published: 07-Sep-2020        Price: US 2500 Onwards        Pages: 124
    The global Radiopharmaceutical market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this indu......
  • (COVID-19 Version) Global Radiopharmaceutical Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 06-Sep-2020        Price: US 3000 Onwards        Pages: 91
    Summary Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy fo......
  • Global Radiopharmaceutical Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 03-Sep-2020        Price: US 3400 Onwards        Pages: 124
    The Radiopharmaceutical market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Radiopharmaceutical market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Radiopharmaceutical market. The report focuses on well-known providers in the global Radiopharmaceutical industry, market segments, competition, and......
  • 2015-2025 Global Radiopharmaceutical Market Research by Type, End-Use and Region (COVID-19 Version)
    Published: 27-Aug-2020        Price: US 2900 Onwards        Pages: 120
    Summary Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy fo......
  • (Post-pandemic Era)-Global Radiation Dose Management Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type
    Published: 20-Aug-2020        Price: US 4860 Onwards        Pages: 99
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Radiation Dose Management growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in......
  • COVID-19 World Radiopharmaceutical Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 14-Aug-2020        Price: US 2800 Onwards        Pages: 91
    Summary Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy fo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs